PRKAR1A and cancer: Although a TCGA analysis identified MEN1 and PRKAR1A as putative cancer genes in ACC, the low frequency of mutations—4.7% and 2.3% for MEN1 and PRKAR1A, respectively—render their importance in this disease at best marginal [30].